Nanoligent

NaDeNo

This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Prosemble

This biotechnology company develops an artificial intelligence and nanotechnology platform to design protein-based nanoparticle systems for precise drug delivery to cancer patients.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

NaNotics

This biopharmaceutical company develops subtractive nanoparticles that capture and clear pathogenic molecules from the blood to treat cancer and inflammatory diseases in humans and dogs.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Matrisome Bio

This company develops nanobody-based therapies targeting the extracellular matrix to treat patients with metastatic solid tumours and chronic diseases.

Cellemedy

The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.